The pharmaceutical regulatory process
著者
書誌事項
The pharmaceutical regulatory process
（Drugs and the pharmaceutical sciences, v. 144）
M. Dekker, c2005
大学図書館所蔵 件 / 全4件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes bibliographies and index
内容説明・目次
内容説明
Providing in-depth coverage of the procedures utilized by pharmaceutical companies for regulatory compliance, this reference describes the history and development of regulations, standards, and guidelines that affect pharmaceutical product approval and commercial sale in the United States-standing alone as the only authoritative guide to address the complex web of regulatory requirements, application processes, and quality control issues influencing the pharmaceutical industry.
目次
Pharmaceutical Regulation Before and After the Food, Drug, and Cosmetic Act. New Drug Approval Process: Before and After 1962. FDA Regulation of Biological Products. Generic Drug Approval Process: Pre-1984 History Concerning Generic Drugs. Generic Drug Approval Process: Post 1984: Waxman-Hatch Reform. Food and Drug Administration Modernization Act. FDA's Antibiotic Regulatory Scheme: Then and Now. Pioneer and Generic Drugs: Balance Between Product Life Cycle Extension and Anti-Competitive Behavior. The Influence of the Prescription Drug User Fee Act on the Approval Process. Clinical Research Requirements for New Drug Applications. Active Pharmaceutical Ingredients. Obtaining Approval of a New Drug . Obtaining Approval of a Generic Drug. Current Good Manufacturing Practice and the Drug Approval Process. CMC Post-Approval Regulatory Affairs: Constantly Managing Change. The Influence of the USP on the Drug Approval Process. Ways and Means to U.S. Registration of Foreign Drugs. Common Technical Document-Quality (M4-Q): One Regulatory Participant's Perspective. 21 CFR Part 11: Compliance and Beyond. Marketing and Advertising Promotion: The Impact of Government Regulations. Approval and Marketing of Nonprescription or OTC Human Drugs.
「Nielsen BookData」 より